Fingolimod effects on the brain are mediated through biochemical modulation of bioenergetics, autophagy, and neuroinflammatory networks
Mehdi Mirzaei(AGRF Ltd), Stuart L. Graham(The University of Sydney), Yuyi You(Macquarie University), Nitin Chitranshi(Macquarie University), A Turner(Macquarie University), João A. Paulo(Harvard University), Vivek Gupta(Deakin University), Paul A. Haynes(Macquarie University), Roshana Vander Wall(Macquarie University), Matthew J. Fitzhenry(AGRF Ltd), Ardeshir Amirkhani(AGRF Ltd), Joel M. Chick(Harvard University), Alexander Klistorner(Macquarie University), Devaraj Basavarajappa(Macquarie University), Veer K. Gupta(Deakin University), Morteza Abyadeh(Virginia Commonwealth University)
Cited by 20
Related Papers
The burden of bacterial antimicrobial resistance in the WHO European region in 2019: a cross-country systematic analysis
|The Lancet Public Health|2022|350
Global, regional, and national incidence of six major immune-mediated inflammatory diseases: findings from the global burden of disease study 2019
|EClinicalMedicine|2023|132
Amyloid-beta and tau protein beyond Alzheimer’s disease
|Neural Regeneration Research|2023|98
Cdkal1, a type 2 diabetes susceptibility gene, regulates mitochondrial function in adipose tissue
|Molecular Metabolism|2017|73